BMJ State of the Art reviews summarize the ongoing developments in a variety of medical research fields. These 5,000-word articles offer specialists, academicians, and researchers the latest thinking on a broad range of topics. Review the current five most popular reviews of 2023 listed below and Register for Email Alerts when a new review is published.
Long covid can affect people across the spectrum of disease severity. It can involve many systems, including the respiratory, cardiovascular, neurological, gastrointestinal, and musculoskeletal systems. This review summarizes studies of the long-term effects of covid-19 in hospitalized and non-hospitalized patients. Risk factors for acute covid-19 and long covid and possible therapeutic options are also discussed. Read review >
Hepatorenal syndrome is a serious cirrhosis complication associated with high morbidity and mortality. This review summarizes the latest advances in the definition, pathophysiology, diagnosis, and management of hepatorenal syndrome. Read review >
Antiphospholipid syndrome (APS) is a thrombo-inflammatory disease associated with an increased risk of thrombotic events, pregnancy morbidity, and other autoimmune and inflammatory complications. This review summarises the latest evidence on the diagnosis, pathogenesis, and management of antiphospholipid syndrome with a particular focus on updates from the past five years. Read review >
This review summarizes the latest evidence on the epidemiology, risk factors, microbiology, pathogenesis, and treatment of sepsis. It also discusses recently updated US and European sepsis definitions and related clinical criteria. Read review >
Pre-eclampsia is a common disorder that particularly affects first pregnancies. The clinical presentation is highly variable, but hypertension and proteinuria are usually seen. This review summarizes the epidemiology, pathophysiology, prediction, treatment, and long-term consequences of pre-eclampsia. Read review >
Want to know when the latest State of the Art review gets published? Sign up today!